Zyban and Weight Loss
Links shared publicly online about this topic
FDA denies approval of weight-loss drug
endocrinetoday.com — “The FDA has issued a complete response letter regarding the new drug application for combination naltrexone plus bupropion extended-release tabl” View full resource at endocrinetoday.com
Most Recently Shared on February 1, 2011 at 2:07 pm By:
#FDA denies approval of #weight-loss drug http://bit.ly/eDgrg4
Medical News: Weight-Loss Combo Appears Effective - in Primary Care, Obesity from MedPage Today
medpagetoday.com — “A sustained-release formulation combining bupropion and naltrexone (Contrave) appears to be an effective treatment for weight loss in obese patients, researchers have found.” View full resource at medpagetoday.com
Most Recently Shared on July 30, 2010 at 4:16 pm By:
Weight loss combo appears effective: http://bit.ly/cQIBgd
Medical News: Weight-Loss Combo Appears Effective - in Primary Care, Obesity from MedPage Today
medpagetoday.com — “A sustained-release formulation combining bupropion and naltrexone (Contrave) appears to be an effective treatment for weight loss in obese patients, researchers have found.” View full resource at medpagetoday.com
Most Recently Shared on July 30, 2010 at 4:37 pm By:
Weight-Loss Combo Appears Effective (CME/CE) (MedPage Today) -- A sustained-release formulation combining bupropion and.. http://dld.bz/pzez
Orexigen's Empatic Phase 2b results demonstrate weight loss
news-medical.net — “Orexigen Therapeutics, Inc. today announced that its 24-week, Phase 2b trial for Empatic(TM) (bupropion SR/zonisamide SR), the Company's second late stage investigational combination drug for the treatment of obesity, met its primary efficacy endpoint by demonstrating statistically significantly greater weight loss for both Empatic doses compared to monotherapies and placebo.” View full resource at news-medical.net
Most Recently Shared on October 1, 2009 at 7:05 pm By:
Obesity News: Orexigen's Empatic Phase 2b results demonstrate weight loss: Orexigen Therapeutics, .. http://twurl.nl/fj6ep0
Phase 2b study of Empatic for weight loss - MPR
empr.com — “Orexigen Therapeutics announced positive results from its Phase 2b trial for Empatic (bupropion SR/zonisamide SR), its investigational combination drug for the treatment of obesity.” View full resource at empr.com
Most Recently Shared on September 30, 2009 at 4:42 pm By:
MPR News: Phase 2b study of Empatic for weight loss: Orexigen Therapeutics announced positive results .. http://tinyurl.com/ydbvnju
An Effective Regimen for Weight Loss? - QualityPoint Technologies
qualitypointtech.net — “Dr. Leslie Citrome reviews a new study in The Lancet suggesting that combination treatment with naltrexone and bupropion is a viable intervention for obesity. Medscape Psychiatry & Mental Health” View full resource at qualitypointtech.net
Most Recently Shared on August 9, 2010 at 4:42 pm By:
An Effective Regimen for Weight Loss?: Dr. Leslie Citrome reviews a new study in The Lancet suggesting that combin... http://bit.ly/bdxLwX
FDA advisory panel approves combination weight-loss drug
endocrinetoday.com — “The FDA Endocrinologic and Metabolic Drugs Advisory Committee voted 13-7 for approval of combination bupropion plus naltrexone for treatment of obe” View full resource at endocrinetoday.com
Most Recently Shared on December 7, 2010 at 2:48 pm By:
#FDA advisory panel will weigh in on proposed weight-loss drug http://ow.ly/3leCm
Panel Endorses Weight-Loss Drug - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- SILVER SPRING, Md. -- An FDA advisory committee has voted 13-7 that the modest weight-loss benefits of an investigational combination of naltrexone and bupropion (Contrave) outweigh the drug's blood pressure risk.” View full resource at qualitypointtech.net
Most Recently Shared on December 8, 2010 at 3:48 am By:
Panel Endorses Weight-Loss Drug: (MedPage Today) -- SILVER SPRING, Md. -- An FDA advisory committee has voted 13-7... http://bit.ly/fLaZ9R
Weight counseling plus drug may help female smokers | Reuters
reuters.com — “NEW YORK (Reuters Health) - For female smokers worried about gaining weight if they quit, a combination of specialized counseling and the anti-smoking drug Zyban may boost their chances of quitting --” View full resource at reuters.com
Most Recently Shared on March 23, 2010 at 4:00 am By:
Hisham Rana, MD Doctor and Physician
Weight counseling plus drug increases chances of female smokers successfully quiting. http://bit.ly/a8BIdc - #health #tobacco #study
Weight counseling plus drug may help female smokers | Reuters
reuters.com — “NEW YORK (Reuters Health) - For female smokers worried about gaining weight if they quit, a combination of specialized counseling and the anti-smoking drug Zyban may boost their chances of quitting --” View full resource at reuters.com
Most Recently Shared on March 23, 2010 at 2:55 am By:
Weight counseling plus drug may help female smokers: NEW YORK (Reuters Health) - For female smokers w... http://bit.ly/cxWmR7 #health #news
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial : The Lancet
thelancet.com — “Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. By - Prof Frank L Greenway MD,...” View full resource at thelancet.com
Most Recently Shared on August 22, 2010 at 1:41 am By:
Symposier Endocrino Health Site
Combination Weight Loss Drugs Appear Effective for Obesity. http://bit.ly/cjn0cN
Weight Counseling Plus Drug Helps Women Quit Smoking - Drugs.com MedNews
drugs.com — “Behavioral therapy with a focus on weight-counseling combined with the smoking-cessation medicine bupropion (Zyban) is more effective than standard counseling a” View full resource at drugs.com
Most Recently Shared on March 23, 2010 at 8:48 pm By:
Weight Counseling Plus Drug Helps Women Quit Smoking - http://bit.ly/bF2wn4
FDA Says No to Weight-Loss Combo Drug - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- A pill combining bupropion and naltrexone for weight loss (Contrave) won't receive the FDA's approval until its manufacturer, Orexigen, conducts a new clinical trial evaluating its cardiovascular risks, the company said.” View full resource at qualitypointtech.net
Most Recently Shared on February 1, 2011 at 6:01 pm By:
FDA Says No to Weight-Loss Combo Drug: (MedPage Today) -- A pill combining bupropion and naltrexone for weight los... http://bit.ly/eKfeef
Effect of naltrexone plus bupropion on weight loss... [Lancet. 2010] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on August 30, 2010 at 2:18 pm By:
Zack (Sholem) Berger Physician, Doctor, and Internist
Moderately effective medical therapy for #obesity in good-quality trial: bupropion + naltrexone. http://bit.ly/9wSqCT
Weight-Loss Therapy, Medication Help Women Quit Smoking - AOL Health
aolhealth.com — “Combining counseling with the medication bupropion appears to be more effective than counseling alone when it comes to helping women quit smoking, a n” View full resource at aolhealth.com
Most Recently Shared on March 23, 2010 at 3:00 pm By:
Vitamin D Fends Off Asthma, Flu http://i.s-a.cc/9ex44 #flu
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Endocrine Today
The official Twitter for Endocrine Today, clinical news on diabetes and endocrine disorders.
-
MedPage Today
Daily, peer reviewed medical news for clinicians
-
medical_tweets
Advertisement
